|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 264, Issue 5 917-R923, Copyright © 1993 by American Physiological Society
ARTICLES |
D. A. Scheuer and M. H. Perrone
Rhone Poulenc Rorer Central Research, Collegeville, Pennsylvania 19426-0107.
Angiotensin (ANG) can produce a biphasic arterial pressure response, i.e., an increase followed by a decrease. Because ANG type 1 (AT1) receptors mediate the pressor response to ANG, we hypothesized that the opposing depressor action is mediated by the ANG type 2 (AT2) receptors. In thiobutabarbital (Inactin)-anesthetized rats bolus injections of angiotensin III (ANG III; 100, 300, and 1,000 ng/kg iv) produced peak increases in MAP at 20 s of 13.4 +/- 1.4, 20.1 +/- 2, and 27.5 +/- 2.8 mmHg and maximum decreases in pressure at 120 s of -6.3 +/- 1.5, -6.8 +/- 2.2, and -11.4 +/- 4.9 mmHg. During blockade of the AT1 receptors with DuP 753 (losartan, 10 mg/kg) the increases in MAP were eliminated (P < 0.01), whereas the depressor responses (-24.7 +/- 8, -32.8 +/- 9.3, and -42.0 +/- 10.0 mmHg) were significantly (P < 0.05) larger. In separate groups of rats, combined blockade of both AT1 and AT2 receptors eliminated all changes in MAP in response to ANG III, whereas blockade of AT2 receptors alone enhanced the pressor response to ANG III. During AT1 receptor blockade angiotensin II also caused consistent decreases in pressure, which were inhibited during combined blockade of AT1 and AT2 receptors. Therefore, we have demonstrated that the AT2 receptors mediate a depressor response to ANG.
This article has been cited by other articles:
![]() |
S. McMullen and S. C. Langley-Evans Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R85 - R90. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rugale, S. Delbosc, J.-P. Cristol, A. Mimran, and B. Jover Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1744 - H1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. F. de Godoy and A. M. de Oliveira Cross-Talk Between AT1 and AT2 Angiotensin Receptors in Rat Anococcygeus Smooth Muscle J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 333 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ryckwaert, P. Colson, E. Andre, P.-F. Perrigault, G. Guillon, and C. Barberis Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig Br. J. Anaesth., October 1, 2002; 89(4): 599 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lorenzo, M. Ruiz-Ortega, Y. Suzuki, M. Ruperez, V. Esteban, T. Sugaya, and J. Egido Angiotensin III Activates Nuclear Transcription Factor-{kappa}B in Cultured Mesangial Cells Mainly via AT2 Receptors: Studies with AT1 Receptor-Knockout Mice J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1162 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats Hypertension, December 1, 2001; 38(6): 1272 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Henrion, N. Kubis, and B. I. Levy Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation Hypertension, November 1, 2001; 38(5): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Weber and J. H. Lombard Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2196 - H2202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Liu, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He Inhibition of vasoconstriction by angiotensin receptor antagonist GR117289C in arterial grafts Ann. Thorac. Surg., December 1, 2000; 70(6): 2064 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawai, S. Y. Stevens, and C.-S. Liang Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Rowe and B. Dixon Angiotensin III Depressor Action in the Conscious Rabbit Is Blocked by Losartan but not PD 123319 Hypertension, January 1, 2000; 35(1): 130 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. RUAN, M. I. OLIVERIO, T. M. COFFMAN, and W. J. ARENDSHORST Renal Vascular Reactivity in Mice: AngII-Induced Vasoconstriction inAT1A Receptor Null Mice J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2620 - 2630. [Abstract] [Full Text] |
||||
![]() |
T. J. Bivalacqua, A. Dalal, H. C. Champion, and P. J. Kadowitz Role of AT1 receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E838 - E847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Barber, D. B. Sampey, and R. E. Widdop AT2 Receptor Stimulation Enhances Antihypertensive Effect of AT1 Receptor Antagonist in Hypertensive Rats Hypertension, November 1, 1999; 34(5): 1112 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Inoue, Z. Mi, D. G. Gillespie, R. K. Dubey, and E. K. Jackson Angiotensin Receptor Subtype 1 Mediates Angiotensin II Enhancement of Isoproterenol-Induced Cyclic AMP Production in Preglomerular Microvascular Smooth Muscle Cells J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1229 - 1234. [Abstract] [Full Text] |
||||
![]() |
N. HILL-KAPTURCZAK, M. H. KAPTURCZAK, E. R. BLOCK, J. M. PATEL, T. MALINSKI, K. M. MADSEN, and C. C. TISHER Angiotensin II-Stimulated Nitric Oxide Release from Porcine Pulmonary Endothelium Is Mediated by Angiotensin IV J. Am. Soc. Nephrol., March 1, 1999; 10(3): 481 - 491. [Abstract] [Full Text] |
||||
![]() |
M. Tamura, Y. Wanaka, E. J. Landon, and T. Inagami Intracellular Sodium Modulates the Expression of Angiotensin II Subtype 2 Receptor in PC12W Cells Hypertension, February 1, 1999; 33(2): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz, D. Endemann, G. He, J.-S. Li, and E. L. Schiffrin Role of AT2 Receptors in Angiotensin II–Stimulated Contraction of Small Mesenteric Arteries in Young SHR Hypertension, January 1, 1999; 33(1): 366 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Nora, D. H. Munzenmaier, F. M. Hansen-Smith, J. H. Lombard, and A. S. Greene Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1395 - H1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gorelik, L. A. Carbini, and A. G. Scicli Angiotensin 1-7 Induces Bradykinin-Mediated Relaxation in Porcine Coronary Artery J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 403 - 410. [Abstract] [Full Text] |
||||
![]() |
L. Cervenka, C.-T. Wang, and L. G. Navar Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats Am J Physiol Renal Physiol, May 1, 1998; 274(5): F940 - F945. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Champion, M. A. Czapla, and P. J. Kadowitz Responses to angiotensin peptides are mediated by AT1 receptors in the rat Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E115 - E123. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Garrison, H. C. Champion, and P. J. Kadowitz [Pro11,D-Ala12]angiotensin I has rapid onset vasoconstrictor activity in the cat Am J Physiol Endocrinol Metab, December 1, 1997; 273(6): E1059 - E1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Broughton Pipkin and P. N. Baker Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women Hypertension, November 1, 1997; 30(5): 1247 - 1252. [Abstract] [Full Text] |
||||
![]() |
H. C. Champion and P. J. Kadowitz Analysis of the Effects of Candesartan in the Mesenteric Vascular Bed of the Cat Hypertension, November 1, 1997; 30(5): 1260 - 1266. [Abstract] [Full Text] |
||||
![]() |
W. R. Huckle, M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. Fujita, I. I. Stabilito, D. Kim, D. L. Ondeyka, et al. Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis Circulation, March 1, 1996; 93(5): 1009 - 1019. [Abstract] [Full Text] |
||||
![]() |
D. H. Munzenmaier and A. S. Greene Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure Hypertension, March 1, 1996; 27(3): 760 - 765. [Abstract] [Full Text] |
||||
![]() |
T. Ichiki, Y. Kambayashi, and T. Inagami Multiple Growth Factors Modulate mRNA Expression of Angiotensin II Type-2 Receptor in R3T3 Cells Circ. Res., December 1, 1995; 77(6): 1070 - 1076. [Abstract] [Full Text] |
||||
![]() |
V. Cachofeiro, R. Maeso, E. Rodrigo, J. Navarro, L. M. Ruilope, and V. Lahera Nitric Oxide and Prostaglandins in the Prolonged Effects of Losartan and Ramipril in Hypertension Hypertension, August 1, 1995; 26(2): 236 - 243. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |